Summary of Significant Accounting Policies - Schedule of Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Accounting Policies [Line Items]
Revenue	$ 792,324	$ 750,265	$ 766,554
Termination payment	9,888	75,153
Contract Termination
Accounting Policies [Line Items]
Termination payment	566	10,000
Prescription transactions revenue
Accounting Policies [Line Items]
Revenue	577,549	550,738	550,536
Subscription revenue
Accounting Policies [Line Items]
Revenue	86,536	94,410	96,167
Pharma manufacturer solutions revenue
Accounting Policies [Line Items]
Revenue	107,237	85,065	99,425
Other revenue
Accounting Policies [Line Items]
Revenue	$ 21,002	$ 20,052	$ 20,426